The Initiative Group Biosimilars The Netherlands (IBN) is a platform for questions and answers about biosimilars in The Netherlands. It is our objective to remove any hurdles for the responsible uptake of biosimilars. We aim to do so by separating facts from fiction and to share key-information.
With our knowledge we can contribute to timely activities like writing articles, contribute to guidelines, conferences and initiatives to promote the cost effective use of medicines.
The group consists of healthcare professionals, scientists and health insurance companies. Everyone who supports this idea can become a follower of our initiative.